<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01282827</url>
  </required_header>
  <id_info>
    <org_study_id>EBS-optnerv-BCT</org_study_id>
    <nct_id>NCT01282827</nct_id>
  </id_info>
  <brief_title>Paraorbital-Occipital Electric Stimulation in Patients With Optic Neuropathy (BCT_optnerve)</brief_title>
  <official_title>Paraorbital-occipital Alternating Electric Current Stimulation in Patients With Optic Neuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Magdeburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EBS Technologies GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Magdeburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-invasive brain stimulation can increase cortical excitability in the visual system, but
      it is not known if this is of clinical value. The investigators now assessed if repetitive,
      transcranial alternating current stimulation (rtACS) can improve visual field size in
      patients with optic nerve damage. The investigators hypothesized that rtACS would improve
      visual functions with the defective visual field sectors of the visual field (primary outcome
      measure).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection accuracy (DA) change in percent over baseline within defective visual field sectors</measure>
    <time_frame>between baseline and 60 days after stimulation</time_frame>
    <description>Central visus fields were assessed with computer based high-resolution perimetry (HRP). Based on such plots, areas of the visual field were characterized as intact, partially damaged or absolutely impaired (blind).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Parameters 1</measure>
    <time_frame>baseline to 60 days after stimulation</time_frame>
    <description>DA in static and kinetic perimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Parameters 2</measure>
    <time_frame>baseline to 60 days after stimulation</time_frame>
    <description>reaction time (RT) in HRP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Parameters 3</measure>
    <time_frame>baseline to 60 days after stimulation</time_frame>
    <description>visual acuity (VA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Parameters 4</measure>
    <time_frame>baseline to 60 days after stimulation</time_frame>
    <description>contrast vision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EEG parameters</measure>
    <time_frame>baseline to 60 days after stimulation</time_frame>
    <description>EEG power spectra</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Low Vision</condition>
  <arm_group>
    <arm_group_label>rtACS (Verum condition)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repetitive transorbital alternating current stimulation (rtACS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no intervention (Sham stimulation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rtACS (verum condition)</intervention_name>
    <description>Repetitive, transorbital alternating current stimulation (rtACS) was applied with a multi-channel device generating weak current pulses in predetermined firing bursts of 2 to 9 pulses. The amplitude of each current pulse was below 1000 microA. Current intensity was individually adjusted according to how well patients perceived phosphenes, i.e. any sensation of flickering light in response to the rtACS stimulation.</description>
    <arm_group_label>rtACS (Verum condition)</arm_group_label>
    <other_name>Device for electrical stimulation &quot;Brainstim&quot;</other_name>
    <other_name>Hersteller: &quot;ELSTIM&quot;, St. Petersburg, Russland</other_name>
    <other_name>Device number: &quot;07062006&quot;</other_name>
    <other_name>Classification: Class II, Type BF</other_name>
    <other_name>SLG device marking: &quot;5016-07-P/001&quot;</other_name>
    <other_name>Modifications of the device have been performed before the SLG test by &quot;Eurotronics Weißenfelser Straße 67, D-04229 Leipzig&quot;</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo stimulation</intervention_name>
    <description>a clicking sound was presented and the same electrodes montage set-up was used during rtACS and placebo stimulation, except that placebo patients received no current (stimulator turned off).</description>
    <arm_group_label>Placebo stimulation</arm_group_label>
    <other_name>Device for electrical stimulation &quot;Brainstim&quot;</other_name>
    <other_name>Hersteller: &quot;ELSTIM&quot;, St. Petersburg, Russland</other_name>
    <other_name>Device number: &quot;07062006&quot;</other_name>
    <other_name>Classification: Class II, Type BF</other_name>
    <other_name>SLG device marking: &quot;5016-07-P/001&quot;</other_name>
    <other_name>Modifications of the device have been performed before the SLG test by &quot;Eurotronics Weißenfelser Straße 67, D-04229 Leipzig&quot;</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  residual vision

          -  patients with optic nerv lesion

          -  lesion age at least 6 months

          -  stable visual field defect

        Exclusion Criteria:

          -  electric or electronic implants such as pace maker

          -  any metal artefacts in head and truncus

          -  epilepsia

          -  photosensitive epilepsy as determines by EEG

          -  autoimmune illnesses in acute stage

          -  mental diseases such e.g. schizophrenia etc.

          -  diabetes causing diabetic retinopathy

          -  addiction

          -  high blood pressure

          -  unstable or high level intraocular pressure (i.e. &gt; 27 mmHg)

          -  retinitis pigmentosa

          -  pathological nystagmus

          -  presence of an un-operated tumor or tumor recidive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard A Sabel, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Magdeburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Neurologie, Charité Campus Mitte, Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut für Medizinische Psychologie, Leipziger Str. 44</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2011</study_first_submitted>
  <study_first_submitted_qc>January 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2011</study_first_posted>
  <last_update_submitted>January 25, 2011</last_update_submitted>
  <last_update_submitted_qc>January 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Bernhard A. Sabel</name_title>
    <organization>University of Magdeburg</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

